• PDA TR 29

PDA TR 29

  • Technical Report 29, Revised 2012 (TR 29) Points to Consider for Cleaning Validation
  • Report / Survey by Parenteral Drug Association, 12/01/2012
  • Category: PDA

$325.00 $163.00

It has been 14 years since PDA published the original Technical Report No. 29, and cleaning validation continues to play an important role in reducing the possibility of product contamination from pharmaceutical manufacturing equipment. Cleaning validation demonstrates that the cleaning process adequately and consistently removes product residues, process residues and environmental contaminants from the manufacturing equipment/system, so that this equipment/system can be safely used for the manufacture of specified subsequent products (which may be the same or a different product). The 2012 revision of Technical Report 29 builds on the 1998 report and utilizes principles and specific wording from the 2010 PDA Technical Report No. 49, Points to Consider for Biotechnology Cleaning Validation. It presents updated information that is aligned with lifecycle approaches to validation and the International Conference on Harmonisation (ICH) guidelines Q8 (R2) - Pharamaceutical Development, Q9 - Quality Risk Management and Q10 - Pharmaceutical Quality System. Also, this report aims to assist readers who want to create or benchmark a cleaning validation program for their equipment and facilities. Written by a Task Force composed of European and North American professionals from pharmaceutical manufacturers, cleaning chemical suppliers, and consulting companies, the report has undergone a global, technical peer review to ensure concepts, terminology, and practices presented are reflective of sound science and can be used globally.
PDF

All of our standards document are available in PDF (Portable Document Format), an electronic, downloadable format.You will be able to download the file in your account downloads.

Multi-User Access

After purchasing, you have the ability to assign each license to a specific user.

Printable

At any time, you are permitted to make printed copies for your and your members' reference use.

PDA TR 54-2

PDA TR 54-2

Technical Report No. 54-2 (TR 54-2) Implementation of Quality Risk Management for Pharmaceutical and..

$163.00 $325.00

PDA TR 3

PDA TR 3

Technical Report No. 3, Revised 2013 (TR 3) Validation of Dry Heat Processes Used for Depyrogenation..

$163.00 $325.00

PDA TR 43

PDA TR 43

Technical Report No. 43, Revised 2013 (TR 43) Identification and Classification of Nonconformities i..

$163.00 $325.00

PDA TR 63

PDA TR 63

Technical Report No. 63 (TR 63) Quality Requirements for the Extemporaneous Preparation of Clinical ..

$163.00 $325.00